These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32222619)

  • 1. Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers.
    Floresta G; Carotti A; Ianni F; Sorrenti V; Intagliata S; Rescifina A; Salerno L; Di Michele A; Sardella R; Pittalà V
    Bioorg Chem; 2020 Jun; 99():103777. PubMed ID: 32222619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region.
    Floresta G; Fallica AN; Romeo G; Sorrenti V; Salerno L; Rescifina A; Pittalà V
    Bioorg Chem; 2020 Nov; 104():104310. PubMed ID: 33010625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme oxygenase inhibition by 1-aryl-2-(1h-imidazol-1-yl/1h-1,2,4-triazol-1-yl)ethanones and their derivatives.
    Roman G; Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
    ChemMedChem; 2010 Sep; 5(9):1541-55. PubMed ID: 20652928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring.
    Roman G; Riley JG; Vlahakis JZ; Kinobe RT; Brien JF; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2007 May; 15(9):3225-34. PubMed ID: 17339115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Activity Relationships of 1,2-Disubstituted Benzimidazoles: Selective Inhibition of Heme Oxygenase-2 Activity.
    Kong X; Vukomanovic D; Nakatsu K; Szarek WA
    ChemMedChem; 2015 Aug; 10(8):1435-41. PubMed ID: 26083133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone.
    Roman G; Rahman MN; Vukomanovic D; Jia Z; Nakatsu K; Szarek WA
    Chem Biol Drug Des; 2010 Jan; 75(1):68-90. PubMed ID: 19954435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent
    Fallica AN; Sorrenti V; D'Amico AG; Salerno L; Romeo G; Intagliata S; Consoli V; Floresta G; Rescifina A; D'Agata V; Vanella L; Pittalà V
    J Med Chem; 2021 Sep; 64(18):13373-13393. PubMed ID: 34472337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors.
    Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
    J Med Chem; 2006 Jul; 49(14):4437-41. PubMed ID: 16821802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of rat and mouse microsome heme oxygenase by derivatives of imidazole and benzimidazole.
    Hum M; McLaughlin BE; Kong X; Vlahakis JZ; Vukomanovic D; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1454-1461. PubMed ID: 28793202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors.
    Vukomanovic D; McLaughlin B; Rahman MN; Vlahakis JZ; Roman G; Dercho RA; Kinobe RT; Hum M; Brien JF; Jia Z; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2010 Apr; 88(4):480-6. PubMed ID: 20555417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
    Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications.
    Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
    Curr Med Chem; 2018; 25(42):5803-5821. PubMed ID: 30674243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
    Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
    Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors.
    Salerno L; Amata E; Romeo G; Marrazzo A; Prezzavento O; Floresta G; Sorrenti V; Barbagallo I; Rescifina A; Pittalà V
    Eur J Med Chem; 2018 Mar; 148():54-62. PubMed ID: 29454190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.
    Intagliata S; Salerno L; Ciaffaglione V; Leonardi C; Fallica AN; Carota G; Amata E; Marrazzo A; Pittalà V; Romeo G
    Eur J Med Chem; 2019 Dec; 183():111703. PubMed ID: 31550661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis.
    Floresta G; Pittalà V; Sorrenti V; Romeo G; Salerno L; Rescifina A
    Bioorg Chem; 2018 Dec; 81():334-339. PubMed ID: 30189413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
    Salerno L; Pittalà V; Romeo G; Modica MN; Siracusa MA; Di Giacomo C; Acquaviva R; Barbagallo I; Tibullo D; Sorrenti V
    Bioorg Med Chem; 2013 Sep; 21(17):5145-53. PubMed ID: 23867390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1/2 and human cytochromes P450 3A4 and 2D6.
    Hum M; McLaughlin BE; Roman G; Vlahakis JZ; Szarek WA; Nakatsu K
    J Pharmacol Exp Ther; 2010 Sep; 334(3):981-7. PubMed ID: 20501634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.
    Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
    J R Soc Interface; 2013 Jan; 10(78):20120697. PubMed ID: 23097500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring.
    Vlahakis JZ; Hum M; Rahman MN; Jia Z; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2009 Mar; 17(6):2461-75. PubMed ID: 19268600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.